<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37514967</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Fatigue Potentially Reduces the Effect of Transcranial Magnetic Stimulation on Depression Following COVID-19 and Its Vaccination.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1151</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines11071151</ELocationID><Abstract><AbstractText>COVID-19's long-term effects, known as Long-COVID, present psychiatric and physical challenges in recovered patients. Similarly, rare long-term post-vaccination side effects, resembling Long-COVID, are emerging (called Post-Vaccine). However, effective treatments for both conditions are scarce. Our clinical experience suggests that transcranial magnetic stimulation (TMS) often aids recovery in Long-COVID and Post-Vaccine patients. However, its effectiveness is reduced in patients with severe fatigue. Therefore, we retrospectively analysed Tokyo TMS Clinic's outpatient records (60 in total; mean age, 38 years) to compare Long-COVID and post-vaccine patients' characteristics and symptoms, assess the impact of TMS on their symptoms, and investigate the role of fatigue in depression recovery with TMS. The primary outcome was the regression coefficient of the initial fatigue score on depression score improvement using TMS. Secondary outcomes included psychiatric/physical scores before and after TMS and their improvement rates. We found no differences in the initial symptoms and background factors between Long-COVID and Post-Vaccine patients. After ten TMS sessions, all psychiatric and physical symptom scores improved significantly. TMS improves depression, insomnia, anxiety, and related neuropsychiatric symptoms, which were the primary complaints in this study. Thus, we conclude that TMS improves depression and anxiety. The effectiveness of TMS in treating depression in Long-COVID and Post-Vaccine patients decreased as fatigue severity increased. In conclusion, TMS relieved depressive symptoms following COVID-19 and vaccination; however, fatigue may hinder its effectiveness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamamuta</LastName><ForeName>Ayane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tokyo TMS Clinic, Tokyo 150-0021, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takagi</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Tokyo TMS Clinic, Tokyo 150-0021, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Mizuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tokyo TMS Clinic, Tokyo 150-0021, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurihara</LastName><ForeName>Kana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Tokyo TMS Clinic, Tokyo 150-0021, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibata</LastName><ForeName>Hibiki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Tokyo TMS Clinic, Tokyo 150-0021, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Kanata</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Tokyo TMS Clinic, Tokyo 150-0021, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hata</LastName><ForeName>Katsuhiko</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4778-3036</Identifier><AffiliationInfo><Affiliation>Tokyo TMS Clinic, Tokyo 150-0021, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physics, Tokyo University of Science, Tokyo 162-8601, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Research Center for Mathematical Medicine, Tokyo 183-0014, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sports and Medical Science, Graduate School of Emergency Medical System, Kokushikan University, Tokyo 206-8515, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KAKENHI 21H03327</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>KAKENHI 21H03327</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>29303</GrantID><Agency>The Watanabe Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">transcranial magnetic stimulation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37514967</ArticleId><ArticleId IdType="pmc">PMC10383898</ArticleId><ArticleId IdType="doi">10.3390/vaccines11071151</ArticleId><ArticleId IdType="pii">vaccines11071151</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Efstathiou V., Stefanou M.I., Demetriou M., Siafakas N., Makris M., Tsivgoulis G., Zoumpourlis V., Kympouropoulos S.P., Tsoporis J.N., Spandidos D.A., et al. Long COVID and neuropsychiatric manifestations (Review) Exp. Ther. Med. 2022;23:363. doi: 10.3892/etm.2022.11290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou T.M., Joca S., Wegener G., Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19&#x2014;A systematic review. Brain Behav. Immun. 2021;97:328&#x2013;348. doi: 10.1016/j.bbi.2021.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourmistrova N.W., Solomon T., Braude P., Strawbridge R., Carter B. Long-term effects of COVID-19 on mental health: A systematic review. J. Affect. Disord. 2022;299:118&#x2013;125. doi: 10.1016/j.jad.2021.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.11.031</ArticleId><ArticleId IdType="pmc">PMC8758130</ArticleId><ArticleId IdType="pubmed">34798148</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Stafford J., Moltrecht B., Huggins C.F., Kwong A.S., Shaw R.J., Zaninotto P., Patel K., Silverwood R.J., McElroy E. Psychological distress, depression, anxiety, and life satisfaction following COVID-19 infection: Evidence from 11 UK longitudinal population studies. Lancet Psychiatry. 2022;9:894&#x2013;906. doi: 10.1016/S2215-0366(22)00307-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00307-8</ArticleId><ArticleId IdType="pmc">PMC9560745</ArticleId><ArticleId IdType="pubmed">36244359</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., Poletti S., Benedetti F. Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment. CNS Drugs. 2022;36:681&#x2013;702. doi: 10.1007/s40263-022-00931-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifian-Dorche M., Bahmanyar M., Sharifian-Dorche A., Mohammadi P., Nomovi M., Mowla A. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J. Neurol. Sci. 2021;428:117607. doi: 10.1016/j.jns.2021.117607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117607</ArticleId><ArticleId IdType="pmc">PMC8330139</ArticleId><ArticleId IdType="pubmed">34365148</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurol. Scand. 2022;145:5&#x2013;9. doi: 10.1111/ane.13550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13550</ArticleId><ArticleId IdType="pmc">PMC8653194</ArticleId><ArticleId IdType="pubmed">34750810</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Handunnetthi L., Saatci D., Pan J., Katikireddi S.V., Razvi S., Hunt D., Mei X.W., Dixon S., Zaccardi F., et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat. Med. 2021;27:2144&#x2013;2153. doi: 10.1038/s41591-021-01556-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01556-7</ArticleId><ArticleId IdType="pmc">PMC8629105</ArticleId><ArticleId IdType="pubmed">34697502</ArticleId></ArticleIdList></Reference><Reference><Citation>Dag Berild J., Bergstad Larsen V., Myrup Thiesson E., Lehtonen T., Grosland M., Helgeland J., Wolhlfahrt J., Vinslov Hansen J., Palmu A.A., Hviid A. Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries. JAMA Netw. Open. 2022;5:e2217375. doi: 10.1001/jamanetworkopen.2022.17375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.17375</ArticleId><ArticleId IdType="pmc">PMC9198750</ArticleId><ArticleId IdType="pubmed">35699955</ArticleId></ArticleIdList></Reference><Reference><Citation>Assiri S.A., Althaqafi R.M.M., Alswat K., Alghamdi A.A., Alomairi N.E., Nemenqani D.M., Ibrahim Z.S., Elkady A. Post COVID-19 Vaccination-Associated Neurological Complications. Neuropsychiatr. Dis. Treat. 2022;18:137&#x2013;154. doi: 10.2147/NDT.S343438.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S343438</ArticleId><ArticleId IdType="pmc">PMC8818972</ArticleId><ArticleId IdType="pubmed">35140464</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J., Vogel G. Vaccines may cause rare, Long Covid-like symptoms. Science. 2022;375:364&#x2013;366. doi: 10.1126/science.ada0536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.ada0536</ArticleId><ArticleId IdType="pubmed">35084966</ArticleId></ArticleIdList></Reference><Reference><Citation>Seneff S., Nigh G., Kyriakopoulos A.M., McCullough P.A. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs. Food Chem. Toxicol. 2022;164:113008. doi: 10.1016/j.fct.2022.113008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2022.113008</ArticleId><ArticleId IdType="pmc">PMC9012513</ArticleId><ArticleId IdType="pubmed">35436552</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunoni A.R., Chaimani A., Moffa A.H., Razza L.B., Gattaz W.F., Daskalakis Z.J., Carvalho A.F. Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review with Network Meta-analysis. JAMA Psychiatry. 2017;74:143&#x2013;152. doi: 10.1001/jamapsychiatry.2016.3644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2016.3644</ArticleId><ArticleId IdType="pubmed">28030740</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reardon J.P., Solvason H.B., Janicak P.G., Sampson S., Isenberg K.E., Nahas Z., McDonald W.M., Avery D., Fitzgerald P.B., Loo C., et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biol. Psychiatry. 2007;62:1208&#x2013;1216. doi: 10.1016/j.biopsych.2007.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2007.01.018</ArticleId><ArticleId IdType="pubmed">17573044</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumberger D.M., Vila-Rodriguez F., Thorpe K.E., Feffer K., Noda Y., Giacobbe P., Knyahnytska Y., Kennedy S.H., Lam R.W., Daskalakis Z.J., et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): A randomised non-inferiority trial. Lancet. 2018;391:1683&#x2013;1692. doi: 10.1016/S0140-6736(18)30295-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30295-2</ArticleId><ArticleId IdType="pubmed">29726344</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.D., Hieronymus F., Lorentzen R., McGirr A., Ostergaard S.D. The efficacy of repetitive transcranial magnetic stimulation (rTMS) for bipolar depression: A systematic review and meta-analysis. J. Affect. Disord. 2021;279:250&#x2013;255. doi: 10.1016/j.jad.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.10.013</ArticleId><ArticleId IdType="pubmed">33074144</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang K., Li H., Bu X., Li X., Cao L., Liu J., Gao Y., Li B., Qiu C., Bao W., et al. Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: A systematic review and network meta-analysis. Transl. Psychiatry. 2021;11:332. doi: 10.1038/s41398-021-01453-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01453-0</ArticleId><ArticleId IdType="pmc">PMC8163761</ArticleId><ArticleId IdType="pubmed">34050130</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehn S., Eslick G.D., Brakoulias V. A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD) Psychiatr. Q. 2018;89:645&#x2013;665. doi: 10.1007/s11126-018-9566-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11126-018-9566-7</ArticleId><ArticleId IdType="pubmed">29423665</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh T.K., Strawn J.R., Walkup J.T., Croarkin P.E. Repetitive Transcranial Magnetic Stimulation for Generalized Anxiety Disorder: A Systematic Literature Review and Meta-Analysis. Int. J. Neuropsychopharmacol. 2022;25:144&#x2013;146. doi: 10.1093/ijnp/pyab077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ijnp/pyab077</ArticleId><ArticleId IdType="pmc">PMC8832221</ArticleId><ArticleId IdType="pubmed">34791241</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicario C.M., Salehinejad M.A., Felmingham K., Martino G., Nitsche M.A. A systematic review on the therapeutic effectiveness of non-invasive brain stimulation for the treatment of anxiety disorders. Neurosci. Biobehav. Rev. 2019;96:219&#x2013;231. doi: 10.1016/j.neubiorev.2018.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2018.12.012</ArticleId><ArticleId IdType="pubmed">30543906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun N., He Y., Wang Z., Zou W., Liu X. The effect of repetitive transcranial magnetic stimulation for insomnia: A systematic review and meta-analysis. Sleep Med. 2021;77:226&#x2013;237. doi: 10.1016/j.sleep.2020.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2020.05.020</ArticleId><ArticleId IdType="pubmed">32830052</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisicaro F., Lanza G., Grasso A.A., Pennisi G., Bella R., Paulus W., Pennisi M. Repetitive transcranial magnetic stimulation in stroke rehabilitation: Review of the current evidence and pitfalls. Ther. Adv. Neurol. Disord. 2019;12:1756286419878317. doi: 10.1177/1756286419878317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756286419878317</ArticleId><ArticleId IdType="pmc">PMC6763938</ArticleId><ArticleId IdType="pubmed">31598137</ArticleId></ArticleIdList></Reference><Reference><Citation>Dionisio A., Duarte I.C., Patricio M., Castelo-Branco M. The Use of Repetitive Transcranial Magnetic Stimulation for Stroke Rehabilitation: A Systematic Review. J. Stroke Cerebrovasc. Dis. 2018;27:1&#x2013;31. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2017.09.008</ArticleId><ArticleId IdType="pubmed">29111342</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y., Mizuno K., Ishii A., Wada Y., Tanaka M., Tazawa S., Onoe K., Fukuda S., Kawabe J., Takahashi K., et al. Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An (1)(1)C-(R)-PK11195 PET Study. J. Nucl. Med. 2014;55:945&#x2013;950. doi: 10.2967/jnumed.113.131045.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.113.131045</ArticleId><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y., Steinberg J.G., Delliaux S. Chronic fatigue syndrome: Acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins. J. Intern. Med. 2012;272:74&#x2013;84. doi: 10.1111/j.1365-2796.2011.02488.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02488.x</ArticleId><ArticleId IdType="pubmed">22112145</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., Lutgehetmann M., Hagel C., Sperhake J.P., Schroder A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A., Lu P., Geraghty A.C., Song E., Lee M.H., Wood J., O&#x2019;Dea M.R., Dutton S., Shamardani K., Nwangwu K., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e16. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Al-Hadrawi D.S., Almulla A.F., Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: A proof of concept and mechanism study. Mol. Psychiatry. 2022 doi: 10.1038/s41380-022-01836-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E., Hall K.H., Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic. Dis. Transl. Med. 2021;7:14&#x2013;26. doi: 10.1016/j.cdtm.2020.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir-Moghtadaei A., Caballero R., Fried P., Fox M.D., Lee K., Giacobbe P., Daskalakis Z.J., Blumberger D.M., Downar J. Concordance Between BeamF3 and MRI-neuronavigated Target Sites for Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex. Brain Stimul. 2015;8:965&#x2013;973. doi: 10.1016/j.brs.2015.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2015.05.008</ArticleId><ArticleId IdType="pmc">PMC4833442</ArticleId><ArticleId IdType="pubmed">26115776</ArticleId></ArticleIdList></Reference><Reference><Citation>Beam W., Borckardt J.J., Reeves S.T., George M.S. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimul. 2009;2:50&#x2013;54. doi: 10.1016/j.brs.2008.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2008.09.006</ArticleId><ArticleId IdType="pmc">PMC2882797</ArticleId><ArticleId IdType="pubmed">20539835</ArticleId></ArticleIdList></Reference><Reference><Citation>Rush A.J., Trivedi M.H., Ibrahim H.M., Carmody T.J., Arnow B., Klein D.N., Markowitz J.C., Ninan P.T., Kornstein S., Manber R., et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol. Psychiatry. 2003;54:573&#x2013;583. doi: 10.1016/S0006-3223(02)01866-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3223(02)01866-8</ArticleId><ArticleId IdType="pubmed">12946886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: Validity of a brief depression severity measure. J. Gen. Intern. Med. 2001;16:606&#x2013;613. doi: 10.1046/j.1525-1497.2001.016009606.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer R.L., Kroenke K., Williams J.B., Lowe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch. Intern. Med. 2006;166:1092&#x2013;1097. doi: 10.1001/archinte.166.10.1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Institutes of Health; Washington, DC, USA: 2015. The National Academies Collection.</Citation></Reference><Reference><Citation>Kuratsune H. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Brain Nerve. 2018;70:11&#x2013;18. doi: 10.11477/mf.1416200944.</Citation><ArticleIdList><ArticleId IdType="doi">10.11477/mf.1416200944</ArticleId><ArticleId IdType="pubmed">29348370</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin P.C., Steyerberg E.W. The number of subjects per variable required in linear regression analyses. J. Clin. Epidemiol. 2015;68:627&#x2013;636. doi: 10.1016/j.jclinepi.2014.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2014.12.014</ArticleId><ArticleId IdType="pubmed">25704724</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefaucheur J.P., Chalah M.A., Mhalla A., Palm U., Ayache S.S., Mylius V. The treatment of fatigue by non-invasive brain stimulation. Neurophysiol. Clin. 2017;47:173&#x2013;184. doi: 10.1016/j.neucli.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2017.03.003</ArticleId><ArticleId IdType="pubmed">28410876</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeken C., De Raedt R. Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression. Dialogues Clin. Neurosci. 2011;13:139&#x2013;145. doi: 10.31887/DCNS.2011.13.1/cbaeken.</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/DCNS.2011.13.1/cbaeken</ArticleId><ArticleId IdType="pmc">PMC3181968</ArticleId><ArticleId IdType="pubmed">21485753</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.J., Kim W.R., Chi S.E., Lee K.H., Park E.H., Chae J.H., Park S.K., Kim H.T., Choi J.S. Repetitive transcranial magnetic stimulation protects hippocampal plasticity in an animal model of depression. Neurosci. Lett. 2006;405:79&#x2013;83. doi: 10.1016/j.neulet.2006.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2006.06.023</ArticleId><ArticleId IdType="pubmed">16839687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ressler K.J., Mayberg H.S. Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic. Nat. Neurosci. 2007;10:1116&#x2013;1124. doi: 10.1038/nn1944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1944</ArticleId><ArticleId IdType="pmc">PMC2444035</ArticleId><ArticleId IdType="pubmed">17726478</ArticleId></ArticleIdList></Reference><Reference><Citation>George M.S., Taylor J.J. A Clinical Guide to Transcranial Magnetic Stimulation. Oxford University; Oxford, UK: 2014. Theoretical basis for transcranial magnetic stimulation; pp. 1&#x2013;7.</Citation></Reference><Reference><Citation>Schiena G., Franco G., Boscutti A., Delvecchio G., Maggioni E., Brambilla P. Connectivity changes in major depressive disorder after rTMS: A review of functional and structural connectivity data. Epidemiol. Psychiatr. Sci. 2021;30:e59. doi: 10.1017/S2045796021000482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S2045796021000482</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021;384:403&#x2013;416. doi: 10.1056/NEJMoa2035389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., Perez Marc G., Moreira E.D., Zerbini C., et al. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. N. Engl. J. Med. 2020;383:2603&#x2013;2615. doi: 10.1056/NEJMoa2034577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy W.J., Longo D.L. A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination. N. Engl. J. Med. 2022;386:394&#x2013;396. doi: 10.1056/NEJMcibr2113694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2113694</ArticleId><ArticleId IdType="pubmed">34818473</ArticleId></ArticleIdList></Reference><Reference><Citation>Renna M.E., O&#x2019;Toole M.S., Spaeth P.E., Lekander M., Mennin D.S. The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: A systematic review and meta-analysis. Depress. Anxiety. 2018;35:1081&#x2013;1094. doi: 10.1002/da.22790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/da.22790</ArticleId><ArticleId IdType="pubmed">30199144</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuron L., Miller A.H. Immune system to brain signaling: Neuropsychopharmacological implications. Pharmacol. Ther. 2011;130:226&#x2013;238. doi: 10.1016/j.pharmthera.2011.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2011.01.014</ArticleId><ArticleId IdType="pmc">PMC3072299</ArticleId><ArticleId IdType="pubmed">21334376</ArticleId></ArticleIdList></Reference><Reference><Citation>Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24&#x2013;31. doi: 10.1016/j.it.2005.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2005.11.006</ArticleId><ArticleId IdType="pmc">PMC3392963</ArticleId><ArticleId IdType="pubmed">16316783</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya J.G., Holmes T.H., Anderson J.N., Maecker H.T., Rosenberg-Hasson Y., Valencia I.J., Chu L., Younger J.W., Tato C.M., Davis M.M. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc. Natl. Acad. Sci. USA. 2017;114:E7150&#x2013;E7158. doi: 10.1073/pnas.1710519114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710519114</ArticleId><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Mendoza J., Baker J.H., Vgontzas A.N., Gaines J., Liao D., Bixler E.O. Insomnia symptoms with objective short sleep duration are associated with systemic inflammation in adolescents. Brain Behav. Immun. 2017;61:110&#x2013;116. doi: 10.1016/j.bbi.2016.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.12.026</ArticleId><ArticleId IdType="pmc">PMC5316336</ArticleId><ArticleId IdType="pubmed">28041986</ArticleId></ArticleIdList></Reference><Reference><Citation>Thye A.Y., Law J.W., Tan L.T., Pusparajah P., Ser H.L., Thurairajasingam S., Letchumanan V., Lee L.H. Psychological Symptoms in COVID-19 Patients: Insights into Pathophysiology and Risk Factors of Long COVID-19. Biology. 2022;11:61. doi: 10.3390/biology11010061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology11010061</ArticleId><ArticleId IdType="pmc">PMC8773222</ArticleId><ArticleId IdType="pubmed">35053059</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>